Intraoperative lymphatic mapping and sentinel node biopsy in breast cancer. A 128-case feasibility study;Individualisation du ganglion axillaire sentinelle par colorant lymphotrope dans les cancers du sein. Étude de faisabilité à propos de 128 cas

Chirurgie

Volumn 123, Issue 3, 1998, Pages 239-246

  Rodier, J F ^a   Routiot, T ^a   Mignotte, H ^b   Janser, J C ^a   Bremond, A ^b   Barlier, C ^a   Ghnassia, J P ^a   Treilleux, I ^b   Chassagne, C ^b   Velten, M ^a  

^a CENTRE PAUL STRAUSS   (France)

^b CENTRE LÉON BÉRARD   (France)

Author keywords

Axillary lymphadenectomy; Breast cancer; Lymphatic mapping; Lymphoscintigraphy; Sentinel node

Indexed keywords

AORTA DISSECTION; AORTA SURGERY; ARTICLE; BREAST CANCER; DIAGNOSTIC VALUE; LYMPH NODE BIOPSY; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

EID: 0031810636     PISSN: 00014001     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4001(98)80115-3     Document Type: Article

References (50)

1. Giuliano AE, Kirgan DM, Guenther M, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994 ; 3 : 391-401
2. Albertini J, Cox C, Teatman T. Lymphatic mapping and sentinel node biopsy in the breast cancer patient. Proc Am Soc Clin Oncol 1995 ; 14 : 100
3. Karakousis C, Velez AF, Spellman JE, Scarozza J. The technique of sentinel node biopsy. Eur J Surg Oncol 1996 ; 22 : 271-5
4. Lin PP, Allison DC, Wainstock J. Impact of axillary lymph node dissection on the therapy of breast cancer patients. J Clin Oncol 1993 ; 8 : 1536-44
5. Cady B. Use of primary breast carcinoma characteristics to predict lymph node metastases. Cancer 1997 ; 10 : 1856-61
6. Silverstein MJ, Barth A. Use of primary carcinoma characteristics to predict lymph node metastases. Reply Cancer 1997 ; 10 : 1862-4
7. Barth A, Craig PH, Silverstein MJ. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer 1997 ; 10 : 1918-22
8. Copeland EM. Is axillary dissection necessary for T1 carcinoma of the breast? J Am Coll Surg 1997 ; 184 : 397-8
9. Haffty BG, Ward B, Pathare P, Salem R, Mc Khann C, Beinfeld M et al. Reappraisal of the role of axillary lymph node dissection in the conservative treatment of breast cancer. J Clin Oncol 1997 ; 2 : 691-700
10. Pandelidis SM, Peters KL, Walusimbi MS, Casady RL, Laux SV, Cavanaugh SH et al. The role of axillary dissection in mammographically detected carcinoma. J Am Coll Surg 1997 ; 184 : 341-5
11. Chontos AJ, Maher DP, Ratzer ER, Fenoglio ME. Axillary lymph node dissection: is it required in T1a breast cancer. J Am Coll Surg 1997 ; 184 : 493-8
12. Theodossiou C, Schwarzenberger P, Espinoza-Delgado I, Wynn RB, Schapira DV. Early stage brest cancer: an approach to treatment (review). Oncol Rep 1997 ; 4 : 1305-10
13. Bland KI. Enhancing the accuracy for predictors of axillary nodal metastasis in T1 carcinoma of the breast. Role of selective biopsy with lymphatic mapping. J Am Coll Surg 1996 ; 1983 : 262-4
14. Giuliano AE, Barth A, Spivack B, Beitsch PD, Evans SW. Incidence and predictors of axillary metastasis in T1 carcinoma of the breast. J Am Coll Surg 1996 ; 183 : 185-9
15. Turner RR, Ollila DW, Krasne DL, Giuliano AE. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 1997 ; 3 : 271-8
16. Wang X, Heller R, Van Voorhis N, Cruse CW, Glass F, Fenske N et al. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg 1994 ; 6 : 768-74
17. Ivens D, Hoe AL, Podd TJ, Hamilton CR, Taylor I, Royle GT. Assessment of morbidity from complete axillary dissection. Br J Surg 1992 ; 66 : 136-8
18. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996 ; 276 : 1818-22
19. Statman RC, Jones RC, Cabot MC, Giuliano AE. Sentinel lymphadenectomy. A technique to eliminate axillary dissection in node-negative breast cancer. Proc Am Soc Clin Oncol 1996 ; 167 : 125
20. Giuliano AE. Lymphatic mapping and sentinel node biopsy in breast cancer. JAMA 1997 ; 277 : 791
21. Giuliano AE. Sentinel lymphadenectomy: A new axillary staging procedure for primary breast carcinoma. Breast Dis 1996 ; 7 : 16-7
22. Giuliano AE. Sentinel lymphadenectomy in primary breast carcinoma: an alternative to routine axillary dissection. J Surg Oncol 1996 ; 62 : 75-7
23. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995 ; 3 : 394-401
24. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997 ; 6 : 2345-50
25. Rodier JF, Janser JC, Barlier-Pagel C, Ghnassia JP, Velten M. Sentinel axillary lymphadenectomy with intraoperative lymphatic mapping in breast cancer. Adv Ther 1996 ; 6 : 347-54
26. Rodier JF, Janser JF, David E, Barlier-Pagel C, Ghnassia JP, Velten M. Intraoperative lymphatic mapping and sentinel node biopsy in breast cancer. Int J Oncol 1997 ; 11 : 894
27. Rodier JF, Janser JC, David E, Barlier-Pagel C, Ghnassia JP, Velten M. Intraoperative lymphatic mapping and sentinel node biopsy in breast cancer. Onkologie 1997 ; 20 : 522
28. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977 ; 39 : 456-66
29. Morton DL, Wen DR, Cochran AJ. Management of early stage melanoma by intraoperative lymphatic mapping and selective lymphadenectomy. Surg Oncol Clin North Am 1992 ; 1 : 247-59
30. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992 ; 127 : 392-9
31. Rodier JF, Janser JC. Surgical technical details improving sentinel node identification in breast cancer. Oncol Rep 1997 ; 4 : 281-3
32. Nieweg OR, Kapteijn BAE, Peterse JL, Rutgers EJT, Van Dongen JA, Kroon BBR. Identificatie van de Schildwachtklier bij patienten met mammacarcinoom. Ned Tijdschr Geneeskd 1996 ; 140 : 2235-9
33. Flett MM, Going JJ, Stanton PD, Cooke TG. Intraoperative lymphatic mapping and localisation of the sentinel node in breast cancer. Eur J Surg Oncol 1997 ; 4 : 374
34. Roumen RMH, Valkenburg JGM, Geuskens LM. Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast-cancer. Eur J Surg Oncol 1997 ; 23 : 495-502
35. Alex JC, Krag DN. Gamma-probe guided localization of lymph nodes. Surg Oncol 1993 ; 2 : 137-43
36. Berman CG, Norman J, Cruse CW, Reintgen DS, Clarck RA. Lymphoscintigraphy in malignant melanoma. Ann Plast Surg 1992 ; 28 : 29-32
37. Collet GJ, Pijpers R, Hoekstra OS, Boom R, Meijer S. Sentinel node biopsy in breast cancer using Tc 99 m-colloidal albumin. Eur J Surg Oncol 1996 ; 22 : 430
38. De Cicco C, Cremonesi M, Chinol M, Bartolomei M, Pizzamiglio M, Leonardi L et al. Optimization of axillary lymphoscintigraphy to detect the sentinel node in breast cancer. Tumori 1997 ; 83 : 539-41
39. Reintgen D. More rational and conservative surgical strategies for malignant melanoma using lymphatic mapping and sentinel node biopsy techniques. Curr Opin Oncol 1996 ; 8 : 152-8
40. Perre CI, Rütter JE, Vos PAFM, Hooge P. Technetium -99m-sestamibi uptake in axillary lymph node metastases in breast cancer patients. Eur J Surg Oncol 1997 ; 23 : 142-4
41. Pijpers R, Meijer S, Hoekstra O, Collet G, Comans EFI, Boom RPA et al. Impact of lymphoscintigraphy on sentinel node indentification with technetium -99m-Colloidal albumin in breast cancer. J Nucl Med 1997 ; 3 : 366-8
42. Nathanson SD, Nelson L, Karvelis KC. Rates of flow by technetium 99 m-labeled human serum albumin from peripheral injection sites to sentinel lymph nodes. Ann Surg 1996 ; 3 : 329-35
43. Veronesi U. Sentinel-node biopsy in breast cancer. Lancet 1997 ; 350 : 808-9
44. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1197 ; 349 : 1864-7
45. Berg JW. The significance of axillary node levels in the study of breast carcinoma. Cancer 1955 ; 8 : 776-8
46. Veronesi U, Luini A, Galimberti V. Extent of metastatic axillary involvement in 1 445 cases of breast cancer. Eur J Surg Oncol 1990 ; 16 : 127-33
47. Rosen PP, Lesser ML, Kinne DW, Beattie EJ. Discontinuous or « skip metastases » in breast carcinoma. Analysis of 1 228 axillary dissections. Ann Surg 1983 ; 3 : 276-83
48. Dees EC, Schulman LN, Souba WW, Smith BL. Does information from axillary dissection change treatment in clinically nodenegative patients with breast cancer? An algorithm for assessment of impact of axillary dissection. Ann Surg 1997 ; 3 : 279-87
49. Borgstein PJ, Meijer S, Pijpers R. Intradermal blue dye to identify lymph node in breast cancer. Lancet 1997 ; 349 : 1668-9
50. Crippa F, Agresti R, Seregni E, Greco M, Pascali C, Bogni A et al. Prospective evaluation of fluorine 18 FDG-PET in presurgical staging of the axilla in breast cancer. J Nucl Med 1998 ; 39 : 4-8